Your browser doesn't support javascript.
loading
Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials.
Verma, Subodh; Bhatta, Meena; Davies, Melanie; Deanfield, John E; Garvey, W Timothy; Jensen, Camilla; Kandler, Kristian; Kushner, Robert F; Rubino, Domenica M; Kosiborod, Mikhail N.
Afiliação
  • Verma S; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Bhatta M; Novo Nordisk, Søborg, Denmark.
  • Davies M; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Deanfield JE; NIHR Leicester Biomedical Research Centre, Leicester, UK.
  • Garvey WT; Institute of Cardiovascular Science, University College London, London, UK.
  • Jensen C; Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Kandler K; Novo Nordisk, Søborg, Denmark.
  • Kushner RF; Novo Nordisk, Søborg, Denmark.
  • Rubino DM; Division of Endocrinology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Kosiborod MN; Washington Center for Weight Management and Research, Arlington, VA, USA.
EClinicalMedicine ; 55: 101737, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36467859
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EClinicalMedicine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EClinicalMedicine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá